Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells

We previously published the results of a pilot study showing that vaccination with tumor-loaded dendritic cells (DCs) induced both T and B cell response and produced clinical benefit in the absence of toxicity in patients with relapsed, indolent non-Hodgkin lymphoma (iNHL). The purpose of the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Fucà, Giovanni, Ambrosini, Margherita, Agnelli, Luca, Brich, Silvia, Sgambelluri, Francesco, Mortarini, Roberta, Pupa, Serenella M, Magni, Michele, Devizzi, Liliana, Matteucci, Paola, Cabras, Antonello, Zappasodi, Roberta, De Santis, Francesca, Anichini, Andrea, De Braud, Filippo, Gianni, Alessandro M, Di Nicola, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204168/
https://www.ncbi.nlm.nih.gov/pubmed/34127544
http://dx.doi.org/10.1136/jitc-2020-002240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204168/
https://www.ncbi.nlm.nih.gov/pubmed/34127544
http://dx.doi.org/10.1136/jitc-2020-002240

Ejemplares similares